<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3052972/" ref="ordinalpos=3757&amp;ncbi_uid=3646866&amp;link_uid=PMC3052972" image-link="/pmc/articles/PMC3052972/figure/F1/" class="imagepopup">Figure 1. Peg-IFN decreases Î²-catenin activity in vitro and does so independent of JAK/STAT <span class="highlight" style="background-color:">signaling</span>.  From: PEGYLATED INTERFERON ALPHA TARGETS WNT <span class="highlight" style="background-color:">SIGNALING</span> BY INDUCING NUCLEAR EXPORT OF ?-CATENIN. </a></div><br /><div class="p4l_captionBody"><b>A.</b> Relative luciferase activity following transfection with either TOPFlash or FOPFlash reporter plasmid and treatment with three or four doses of Peg-IFN in HepG2 cells. Experiments were done in triplicate and averaged. (*p&lt;0.05)<b>B.</b> Relative luciferase activity following transfection with either TOPFlash or FOPFlash reporter plasmid and one treatment with Peg-IFN or with one treatment with lithium followed by one dose treatment of Peg-IFN in Hep3Bcells. Experiments were done in triplicate and averaged. (**p&lt;0.005)<b>C.</b> Inhibition of JAK/Stat pathway with AG490 does not reverse the effect of Peg-IFN on Topflash indicating that this effect is independent of the JAK/Stat pathway.</div></div>